APGE美股盘前飙升近30%药物APG777针对特应性皮炎的试验取得积极结果;KALV大涨超15%公司HAE急性发作口服

智通财经
07 Jul
APGE美股盘前飙升近30%药物APG777针对特应性皮炎的试验取得积极结果;KALV大涨超15%公司HAE急性发作口服药EKTERLY获FDA批准;Wolfspeed续升超20%上一交易日暴涨近53%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10